These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 20714839)

  • 1. Poor outcome following aborted orthotopic liver transplantation due to severe porto-pulmonary hypertension.
    Fukazawa K; Pretto EA
    J Hepatobiliary Pancreat Sci; 2010 Jul; 17(4):505-8. PubMed ID: 20714839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid assessment and safe management of severe pulmonary hypertension with milrinone during orthotopic liver transplantation.
    Fukazawa K; Poliac LC; Pretto EA
    Clin Transplant; 2010; 24(4):515-9. PubMed ID: 20002632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary hemodynamics and perioperative cardiopulmonary-related mortality in patients with portopulmonary hypertension undergoing liver transplantation.
    Krowka MJ; Plevak DJ; Findlay JY; Rosen CB; Wiesner RH; Krom RA
    Liver Transpl; 2000 Jul; 6(4):443-50. PubMed ID: 10915166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver transplantation for pulmonary vascular complications of pediatric end-stage liver disease.
    Iqbal CW; Krowka MJ; Pham TH; Freese DK; El Youssef M; Ishitani MB
    J Pediatr Surg; 2008 Oct; 43(10):1813-20. PubMed ID: 18926213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prevalence and the impact of portopulmonary hypertension on postoperative course in patients undergoing liver transplantation.
    Bozbas SS; Eyuboglu FO; Arslan NG; Ergur FO; Karakayali H; Haberal M
    Transplant Proc; 2009 Sep; 41(7):2860-3. PubMed ID: 19765457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term follow-up of portopulmonary hypertension patients after liver transplantation.
    Khaderi S; Khan R; Safdar Z; Stribling R; Vierling JM; Goss JA; Sussman NL
    Liver Transpl; 2014 Jun; 20(6):724-7. PubMed ID: 24648168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Living-donor liver transplantation for moderate or severe porto-pulmonary hypertension accompanied by pulmonary arterial hypertension: a single-centre experience over 2 decades in Japan.
    Ogawa E; Hori T; Doi H; Segawa H; Uemoto S
    J Hepatobiliary Pancreat Sci; 2012 Nov; 19(6):638-49. PubMed ID: 22086457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and Prognosis of Portopulmonary Hypertension in 223 Liver Transplant Recipients.
    Li J; Zhuang Q; Zhang X; Zheng Y; Qiao Z; Zhang J; Shen X; Shen J
    Can Respir J; 2018; 2018():9629570. PubMed ID: 30319722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary hypertension as a predictor of postoperative complications and mortality after liver transplantation.
    De Pietri L; Montalti R; Begliomini B; Reggiani A; Lancellotti L; Giovannini S; Di Benedetto F; Guerrini G; Serra V; Rompianesi G; Pasetto A; Gerunda GE
    Transplant Proc; 2010 May; 42(4):1188-90. PubMed ID: 20534257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver transplantation in precirrhotic biliary tract disease: Portal hypertension is frequently associated with nodular regenerative hyperplasia and obliterative portal venopathy.
    Abraham SC; Kamath PS; Eghtesad B; Demetris AJ; Krasinskas AM
    Am J Surg Pathol; 2006 Nov; 30(11):1454-61. PubMed ID: 17063088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement of pulmonary hypertension after liver transplantation.
    Schott R; Chaouat A; Launoy A; Pottecher T; Weitzenblum E
    Chest; 1999 Jun; 115(6):1748-9. PubMed ID: 10378581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up of portopulmonary hypertension: effect of treatment with epoprostenol.
    Fix OK; Bass NM; De Marco T; Merriman RB
    Liver Transpl; 2007 Jun; 13(6):875-85. PubMed ID: 17539008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of Kidney Function Before and After Orthotopic Liver Transplant: Associations With Length of Hospital Stay, Progression to End-Stage Renal Disease, and Mortality.
    Longenecker JC; Estrella MM; Segev DL; Atta MG
    Transplantation; 2015 Dec; 99(12):2556-64. PubMed ID: 25989501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of severely steatotic grafts in liver transplantation: a matched case-control study.
    McCormack L; Petrowsky H; Jochum W; Mullhaupt B; Weber M; Clavien PA
    Ann Surg; 2007 Dec; 246(6):940-6; discussion 946-8. PubMed ID: 18043095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver transplantation in highest acuity recipients: identifying factors to avoid futility.
    Petrowsky H; Rana A; Kaldas FM; Sharma A; Hong JC; Agopian VG; Durazo F; Honda H; Gornbein J; Wu V; Farmer DG; Hiatt JR; Busuttil RW
    Ann Surg; 2014 Jun; 259(6):1186-94. PubMed ID: 24263317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of liver transplantation outcomes in the pre- vs. post-MELD eras.
    Kanwal F; Dulai GS; Spiegel BM; Yee HF; Gralnek IM
    Aliment Pharmacol Ther; 2005 Jan; 21(2):169-77. PubMed ID: 15679767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcome of liver transplant patients with Budd-Chiari syndrome secondary to myeloproliferative neoplasms.
    Potthoff A; Attia D; Pischke S; Mederacke I; Beutel G; Rifai K; Deterding K; Heiringhoff K; Klempnauer J; Strassburg CP; Manns MP; Bahr MJ
    Liver Int; 2015 Aug; 35(8):2042-9. PubMed ID: 25736096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracorporeal membrane oxygenation rescue therapy in a case of portopulmonary hypertension during liver transplantation: a case report.
    Stratta C; Lavezzo B; Ballaris MA; Panio A; Crucitti M; Andruetto P; Fanelli V; Grosso Marra W; Ranieri MV; Salizzoni M
    Transplant Proc; 2013 Sep; 45(7):2774-5. PubMed ID: 24034045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Living-donor liver transplantation for congenital biliary atresia with porto-pulmonary hypertension and moderate or severe pulmonary arterial hypertension: Kyoto University experience.
    Ogawa E; Hori T; Doi H; Segawa H; Uemoto S
    Clin Transplant; 2014 Sep; 28(9):1031-40. PubMed ID: 24986560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcome of patients with hereditary hemorrhagic telangiectasia and severe hepatic involvement after orthotopic liver transplantation: a single-center study.
    Dupuis-Girod S; Chesnais AL; Ginon I; Dumortier J; Saurin JC; Finet G; Decullier E; Marion D; Plauchu H; Boillot O
    Liver Transpl; 2010 Mar; 16(3):340-7. PubMed ID: 20209594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.